CIK 0001684144 · Non-accelerated filer<br>Smaller reporting company
Zomedica Corp.
Sign in to watch- Ticker
- ZOMDF
- Exchange
- OTC
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- Alberta, Canada
- Entity type
- operating
- Phone
- (734) 369-2555
- Business address
- 1101 TECHNOLOGY DRIVE, SUITE 100, ANN ARBOR, MI, 48108
- Former names
- Zomedica Pharmaceuticals Corp.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 57 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-11-17 | Cohen Robert Director | Grant or award · Stock Appreciation Right | +1,823,107 | 1,823,107 | ||
| 2025-11-17 | Williams Rodney James Director | Grant or award · Stock Appreciation Right | +1,975,033 | 1,975,033 | ||
| 2025-11-17 | Rowe Jeffrey M Director | Grant or award · Stock Appreciation Right | +2,126,959 | 2,126,959 | ||
| 2025-11-13 | Klass Russell Kevin Sr Vice President, Sales | Purchase | +150,000 | $0.10 | $15K | 5,784,101 |
| 2025-11-10 | Klass Russell Kevin Sr Vice President, Sales | Purchase | +120,000 | $0.10 | $12K | 5,634,101 |
| 2025-11-07 | Klass Russell Kevin Sr Vice President, Sales | Purchase | +5,000 | $0.10 | $475 | 5,514,101 |
| 2025-11-06 | Klass Russell Kevin Sr Vice President, Sales | Purchase | +253,007 | $0.08 | $20K | 5,509,101 |
| 2025-08-12 | Klass Russell Kevin Sr Vice President, Sales | Purchase | +250,000 | $0.04 | $10K | 4,510,753 |
| 2025-08-12 | Klass Russell Kevin Sr Vice President, Sales | Purchase | +745,341 | $0.04 | $30K | 5,256,094 |
| 2025-08-11 | Klass Russell Kevin Sr Vice President, Sales | Purchase | +60,723 | $0.04 | $2K | 4,260,753 |
| 2025-08-11 | Klass Russell Kevin Sr Vice President of Sales | Purchase | +250,000 | $0.04 | $10K | 3,950,030 |
| 2025-08-11 | Klass Russell Kevin Sr Vice President of Sales | Purchase | +250,000 | $0.04 | $10K | 4,200,030 |
| 2025-08-08 | Klass Russell Kevin Sr Vice President of Sales | Purchase | +500,000 | $0.04 | $20K | 3,700,030 |
| 2025-06-12 | Blair Anthony K COO | Grant or award · Options to buy Common Stock | +750,000 | 750,000 | ||
| 2025-06-12 | Klass Russell Kevin Sr Vice President of Sales | Grant or award · Options to buy Common Stock | +500,000 | 500,000 | ||
| 2025-06-12 | HEATON LARRY C II CEO | Grant or award · Options to buy Common Stock | +4,000,000 | 4,000,000 | ||
| 2025-06-12 | DeHaan-Fullerton Karen General Counsel | Grant or award · Options to buy Common Stock | +500,000 | 500,000 | ||
| 2025-05-21 | Blair Anthony K COO | Purchase | +36,250 | $0.05 | $2K | 936,250 |
| 2025-05-21 | Blair Anthony K COO | Purchase | +63,750 | $0.05 | $3K | 1,000,000 |
| 2025-05-19 | DeHaan-Fullerton Karen General Counsel/Corporate Secy | Purchase | +104,300 | $0.05 | $5K | 104,300 |
Page 2 of 8 · 143 trades